- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02139176
Assessing Strategies for Increasing Male Involvement in Malawi's Antenatal Program
In sub-Saharan Africa, engaging men in HIV prevention, care, and treatment has proven challenging. Along all steps of the HIV care-seeking cascade, men exhibit worse care-seeking behaviors than women. They are less likely to be tested for HIV, initiate combination antiretroviral therapy (cART), and be retained in cART care. Additionally, men rarely engage in the care of their female sex partners, even though couple care-seeking is associated with marked improvements in condom use within HIV-discordant couples. Option B+, Malawi's program for providing immediate, lifelong combination antiretroviral therapy (cART) to all HIV-infected pregnant women at the time of diagnosis, is an important entry-point for involving male partners in care.
This is a pilot randomized controlled trial (N=200 women) comparing two strategies of male partner involvement within the Option B+ program. In both arms (patient referral and contract referral) women will be encouraged to invite their male partners to accompany them to the clinic for couple HIV counseling and testing. In the contract referral arm, if the couple does not present within one week, the male partner will receive a home visit encouraging them to present to the clinic. We will compare the two arms for 1) uptake of couple HIV counseling and testing (cHCT), 2) uptake of cART for women, and 3) linkage to care for HIV-infected men. Results are expected to inform a larger trial and ultimately improve care-seeking in Malawi's HIV program.
Objective 1: Determine acceptability of male partner recruitment for cHTC within an Option B+ context. We will assess acceptability of eligible females to participate in this pilot RCT and reasons for non-participation.
Objective 2: Assess whether study arm (patient referral versus contract referral) is associated with cHTC uptake. We will conduct a pilot randomized controlled trial (RCT) of male partner recruitment. This study will contain two arms: patient referral and contract referral for uptake of cHTC (primary outcome).
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Central District
-
Lilongwe, Central District, Malawi
- Bwaila District Hospital Antenatal Unit
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
18 years old or 16-17 years old and married
- Pregnant
- Received a positive HIV-test within the last day
- Will be in Lilongwe for the next month
- Able and willing to give locator information for >1 male partner in the Bwaila District Hospital catchment area (either a mobile number, a physical address, or both)
Exclusion Criteria:
- Enrolled/enrolling in the PROMISE study
- Initially Presenting with a male sex partner
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Comparateur actif: Patient referral
Women are given an invitation to give to a male partner inviting them to come to the clinic for important pregnancy information
|
A patient agrees to recruit their partner using the invitation.
Autres noms:
|
Expérimental: contract referral
Same as control.
However, if the male partner does not present, a community worker will trace the partner in the community.
|
A patient agrees to recruit their partner using the invitation.
Autres noms:
A female partner signs a contract saying it is permissible for a community worker to trace a male sex partner in the community.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Number of Women Who Came With Their Partners and Received Couple Counseling and Testing
Délai: three months
|
Based on whether the female partner brings her male partner to the antenatal clinic for couple HIV counseling and testing (as recorded on study case report forms) as the primary measure of uptake.
We will compare time to couple HIV counseling and testing between groups using the Kaplan Meier method and a log rank test.
|
three months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Female First Option B+ Follow-up Visit
Délai: three months
|
It will be assessed whether the female participants return for their first Option B+ visit (using the clinic's routine Option B+ records).
The number retained will be compared.
|
three months
|
Male Linkage to Care
Délai: one month from male presentation to the clinic
|
It will be assessed whether newly diagnosed HIV-infected male partners are linked to care within one month of learning their HIV positive result with their partner.
This will be assessed from abstraction of routine clinic records at Martin Preuss Center.
|
one month from male presentation to the clinic
|
Collaborateurs et enquêteurs
Les enquêteurs
- Chercheur principal: Nora E Rosenberg, PhD, University of North Carolina, Chapel Hill
- Chercheur principal: Mina Hosseinipour, MD, University of North Carolina, Chapel Hill
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 13-3707
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur VIH
-
Icahn School of Medicine at Mount SinaiIRRASRecrutementHémorragie intraventriculaire (HIV)États-Unis
-
Yale UniversityComplétéPrématurité | Nourrissons de très faible poids à la naissance | Hémorragie intraventriculaire (HIV) | Saignement dans le cerveauÉtats-Unis
Essais cliniques sur patient referral
-
Hospital Universitario Reina Sofia de CordobaSpanish Society of Family and Community MedicineComplétéFibrillation auriculaire
-
Centre for Evidence-Based Practice, BelgiumBelgian Red CrossComplétéAccident vasculaire cérébral | BrûluresBelgique
-
University of California, San FranciscoComplété
-
Centre Hospitalier Régional Metz-ThionvilleRecrutementCOVID-19 [feminine] | Qualité de vie | Déficience cognitive | Trouble de stress post-traumatique | Comportement socialFrance
-
CorinRecrutementArthrite du genou | Arthroplastie totale du genou | Remplacement total du genou | Maladie du genouFrance
-
The University of Texas Health Science Center,...Amniotic Fluid Embolism (AFE) FoundationRecrutementEmbolie de liquide amniotiqueÉtats-Unis
-
Assistance Publique - Hôpitaux de ParisComplétéMalformation adénomatoïde kystique congénitale (CCAM)France
-
GE HealthcareRésiliéPression artérielleÉtats-Unis, Inde
-
University of Southern CaliforniaNational Psoriasis FoundationComplétéPsoriasis | La dermatite atopique | AcnéÉtats-Unis